No ano de 2024 foram aceites para publicação 8 artigos científicos:
1. Effectiveness and safety of lenvatinib in a series of advanced well diferentiated thyroid carcinomas from a single tertiary cancer center and literature review.
L. Damásio, A. Figueiredo, J. Maciel, M. Horta, T. N. Silva, J. Simões-Pereira, S. Donato, V. Leite. Minerva Endocrinol (Torino). 2024 Mar 21.
doi: 10.23736/S2724-6507.23.03982-9.
2. Clinical and molecular characterisation of metastatic papillary thyroid cancer according to radioiodine therapy outcomes.
Simões-Pereira, A. Saramago, R. Rodrigues, M. Pojo, C. Pires, M. Horta, D. López-Presa, M. Rito, R. Cabrera, T. C. Ferreira, V. Leite, B. M. Cavaco.
Endocrine. 2023 Dec 16.
doi: 10.1007/s12020-023-03633-y.
Online ahead of print.
3. Treatment of metastatic paraganglioma: experience of a single center.
Veríssimo, C. Regala, I. Damásio, S. Santos, S. Donato, V. Leite.
Endocrine 84, 1250–1257 (2024).
https://doi.org/10.1007/s12020-024-03700-y
4. Identification of germline FOXE1 and somatic MAPK pathway genes alterations in patients with malignant struma ovarii, cleft palate and thyroid cancer.
Pires, A. Saramago, M. M. Moura, J. Li, S. Donato, I. J. Marques, H. Belo, A. C. Machado, R. Cabrera, T. G.
P. Grünewald, V. Leite, B. M. Cavaco.
Int. J. Mol. Sci. 2024, 25(4), 1966; https://doi.org/10.3390/ijms25041966.
5. CHEK2 germline variants identified in familial non-medullary thyroid cancer lead to impaired protein structure and function.
Pires, I. J. Marques, M. Valério, A. Saramago, P. E. Santo, S. Santos, M. Silva, M. M. Moura, J. Matos, T. Pereira, R. Cabrera, D. Lousa, V. Leite, T. M. Bandeiras, J. B. Vicente and B. M. Cavaco.
J Biol Chem. 2024 Feb 15:105767.
doi: 10.1016/j.jbc.2024.105767.
6. Incidentally vs. non-incidentally diagnosed papillary thyroid carcinoma: are there differences?
Cosme, A. Figueiredo, S. Pinheiro, V. Leite.
Eur Thyroid J. 2024 Jul 1;13(4):e240106.
doi: 10.1530/ETJ-24-0106.
Epub ahead of print. PMID: 38968008; PMCID: PMC11301558.
7. Incidental thyroid cancer and overdiagnosis: response to Drs Tsybrovskyy, Sobrinho-Simões, and Tallini.
Cosme, A. Figueiredo, S. Pinheiro, V. Leite
Eur Thyroid J. 2024 Oct 14;13(5):e240296.
doi: 10.1530/ETJ-24-0296. PMID: 39400058; PMCID: PMC11558922.
8. Identification of novel candidate predisposing genes in familial nonmedullary thyroid carcinoma implicating DNA damage repair pathways.
Pires, I. J. Marques, A. Saramago, M. M. Moura, M. Pojo, R. Cabrera, C. Santos, F. Rosário, D. Lousa, J. B. Vicente, T. M. Bandeiras, M. R. Teixeira, V. Leite, B. M. Cavaco.
Int J Cancer. 2025 Jan 1;156(1):130-144.
doi: 10.1002/ijc.35159. Epub 2024 Sep 9. PMID: 39251783.
No ano de 2023 foram aceites para publicação 14 artigos científicos:
- Target therapy for BRAF mutated anaplastic thyroid cancer: a clinical and molecular study.
T. Nunes da Silva, R. Rodrigues, A. Saramago, C. Pires, M. Rito, M. Horta, C. Martins, V. Leite, and B. M. Cavaco.
European Journal of Endocrinology, 2023, 188, 1–8 https://doi.org/10.1093/ejendo/lvac011 - Malignant Hypercalcemia Due to the Ectopic Production of Calcitriol by an Abdominal Liposarcoma.
A.Figueiredo , T. Pereira , R. Cabrera , J. Simões-Pereira , V. Leite.
Cureus. 2023 Jan 6;15(1):e33446. doi: 10.7759/cureus.33446. eCollection 2023 Jan. - Clinical significance of papillary thyroid carcinoma with solid/trabecular growth.
S. L. Pinheiro, P. M. Afonso, I. L. Damásio, J. Simões-Pereira, T. Nunes da Silva, V. Leite.
Clin Endocrinol 06 February 2023.https://doi.org/10.1111/cen.14886 - Differentiated Thyroid Cancer in a Pediatric Population: Estimating the Risk of Recurrence and Evolution Over Time.
I. Damásio1, D. Dias, S. Pinheiro , S. Esteves, V.Leite, R. Santos
Cureus 2023 Jan 28;15(1):e34313. doi: 10.7759/cureus.34313 - Ectopic parathyroid adenoma in a patient with multiple endocrine tumors
I Damásio, I. Carvalho, S. Donato, V. Leite.
Endokrynol Pol. 2023 May 8. doi: 10.5603/EP.a2023.0033. - Tumores neuroendócrinos tratados com análogos da somatostatina em esquema de dosedensidade: experiência de um centro oncológico português.
C. Pereira, S. Magno, I. Claro, V. Leite, M. Brito, A. Moreira.
Revista Portuguesa de Oncologia 2023. - Metastatic follicular thyroid cancer with a longstanding responsiveness to gemcitabine plus oxaliplatin.
D. Dias, I. Damásio, P. Marques, H. Simões, R. Rodrigues, B. M. Cavaco, V. Leite.
Eur Thyroid J. 2023 May 8;12(3):e220227. doi: 10.1530/ETJ-22-0227. - Delayed Presentation of Functioning Metastasis in a Patient with Follicular Thyroid Carcinoma.
M. I. Alexandre, S. Donato, H. Vilar, V. Leite.
Diagnostics (Basel). 2023 Jan 12;13(2):281. doi: 10.3390/diagnostics13020281. - Familial parathyroid tumours-comparison of clinical profiles between syndromes
A. A. Figueiredo, A. Saramago, B. M. Cavaco, J. Simões-Pereira, V. Leite.
J Endocrinol Invest. 2023 Feb 13. doi: 10.1007/s40618-023-02032-4. - Outcomes of lenvatinib therapy in poorly differentiated thyroid carcinoma.
J. Roque, T. Nunes-da-Silva, C. Regala, R. Rodrigues, V. Leite.
Eur Thyroid J. 2023 Mar 28;12(2):e230003. doi: 10.1530/ETJ-23-0003. Print 2023 Apr 1. - Clinical and molecular characterization of parathyroid carcinoma in multiple endocrine neoplasia type 1
S. L. Pinheiro, A. Saramago, B. M. Cavaco, C. Martins, V. Leite and T. Nunes-da-Silva
Endocrine Connections (2023) doi: 10.1530/EC-22-0479. FI 2.9 - SPRY4 as a potential mediator of the anti-tumoral role of macrophages in anaplastic thyroid cancer cells.
A. T. Pinto, M. Pojo, R. Rodrigues, D. P.Sousa, R. Matthiesen, A. S. Carvalho, H. C. Beck, C. Pires, R. Eduardo, J. S. Pereira, V. Leite, B. M. Cavaco
Cancers 2023, 15, 4387. https://doi.org/10.3390/cancers15174387 - Clinical and molecular characterisation of metastatic papillary thyroid cancer according to radioiodine therapy outcomes.
J. Simões-Pereira, A. Saramago, R. Rodrigues, M. Pojo, C. Pires, M. Horta, D. López-Presa, M. Rito, R. Cabrera, T. C. Ferreira, V. Leite, B. M. Cavaco.
Endocrine. 2023 Dec 16. doi: 10.1007/s12020-023-03633-y. Online ahead of print. 14. - Effectiveness and safety of lenvatinib in a series of advanced well differentiated thyroid carcinomas from a single tertiary cancer center and literature review
Inês Damásio, Joana Maciel, Ana Figueiredo, Hélder Simões, Tiago Nunes da Silva, Joana Simões Pereira, Mariana Horta, Rita Santos, Sara Donato, Valeriano Leite
Minerva Endocrinology 2023 (aceite para publicação a 2/10/2023) FI 4.1
No ano de 2022 foram aceites para publicação 17 artigos científicos:
1. Predictive factors for thyroid complications after radiation therapy-data from a cohort of cancer patients closely followed since they were irradiated. Vitoria Duarte, Joana Maciel, Daniela Cavaco, Sara Donato, Inês Damásio, Sara Pinheiro, Ana Figueiredo, Ana Ferreira, Joana S Pereira. Clin Endocrinol (Oxf). 2022;96:728-733.
2. Precocious and accelerated puberty in children with neurofibromatosis type 1: results from a close follow-up of a cohort of 45 patients. Sara Lomelino Pinheiro, Joana Maciel, Daniela Cavaco, Ana Abrantes Figueiredo, Inês Lemos Damásio, Sara Donato, João Passos, Joana Simões-Pereira. Hormones (Athens). 2022. doi: 10.1007/s42000-022-00411-9. Online ahead of print.
3. Entrectinib in the neoadjuvant setting of anaplastic thyroid cancer: a case report. Inês Damásio, Joana Simões-Pereira, Sara Donato, Miguel Rito, Mariana Horta, Pedro Gomes, Branca Cavaco, Valeriano Leite. European Thyroid Journal. 2022 Nov. DOI: 10.1530/ETJ-22-0179. Online ahead of print.
4. Adrenal findings in FDG-PET: analysis of a cohort of 1021 patients from a cancer center. Joana Maciel, Daniela Cavaco, Davide Fraga, Sara Donato, Helder Simões, Rita Sousa, Joana Simões-Pereira. Hormones (Athens). 2022. doi: 10.1007/s42000-022-00423-
5. Giant retrosternal goitre causing lung atelectasis. Figueiredo AA, Simões-Pereira J. Endokrynol Pol. 2022;73(4):794-795. doi: 10.5603/EP.a2022.0043. FI 1.582. Online ahead of print.
6. Preoperative serum inflammation-based scores in medullary thyroid cancer. Figueiredo AA, Esteves S, Moura MM, Marques P, Simões-Pereira J, Leite V. Endocrinol Diabetes y Nutr. 2022. doi: 10.1016/j.endinu.2022.06.007. FI 1.417
7. Clinical outcomes of a cohort of 271 patients with lung metastases from differentiated thyroid carcinoma. Cavaco D, Joana M, Silvestre C, Vilar H, Simões-Pereira J, Leite V. Clin Endocrinol (Oxf). 2022 Fev 22. doi: 10.1111/cen.14700. FI 3,478
8. Diffuse sclerosing variant of papillary thyroid carcinoma: outcomes of 33 cases. Cavaco D, Martins AF, Cabrera R, Vilar H, Leite V. Eur Thyroid J. 2022 Jan 19;11(1):ETJ-21-0020. doi: 10.1530/ETJ-21-0020. FI 3,86
9. X-linked hypophosphatemic rickets: Report of a novel PHEX mutation and cinacalcet as adjuvant therapy in the mineral metabolism control. Cavaco D, Amaro P, Simões-Pereira J, Pereira MC Mod Rheumatol Case Rep. 2022 Jan 7;6(1):145-149. doi: 10.1093/mrcr/rxab031.
10. Giant ovarian cystadenoma in association with Cowden syndrome. Damásio IL, Leite VAPH, Santos RJAMD Endokrynol Pol. 2022;73:796-797. Fator de Impacto (FI) 1,56918.18. doi: 10.5603/EP.a2022.0066. Epub 2022 Aug 16.
11. Flash glucose monitoring and glycemic control in type 1 diabetes with subcutaneous insuline infusion. Pinheiro SL, Bastos M, Barros L, Melo M, Paiva I. Acta Diabetol. 2022;59:509-515. FI 4,087; SJR 1,05
12. Functioning metastasis from adrenocortical carcinoma. C. Cunha, S. Donato, T. Silva, V. Leite. BMJ Case Rep. 2022 Jan 25;15(1):e246742. doi: 10.1136/bcr-2021-246742.
13. Parathyroid carcinoma: Single centre experience. C. Cunha, S. Lomelino Pinheiro, S. Donato, C. T. Bello, H. Simões, T. N. Silva, S. Prazeres, D. Doutel, B. M. Cavaco, V. Leite Clinical Endocrinology. 2022;1–8. DOI: 10.1111/cen.14684.
14. Clinical, Molecular Characterization and Long-Term Follow-Up of a Patient with Neonatal Severe Hyperparathyroidism. Padeira G, Cavaco BM, Virella D, Sá-Couto H, Afonso-Lopes ML. Portuguese Journal of Pediatrics. 2022; 53(1) 440-446.doi.org/10.25754/pjp.2022.24480
15. Response to “Radioiodine Is Molecular Radiotherapy Governed by Predictable Deterministic Radiobiology Expressed in Gray, Not Millicuries” by Kao. Simões-Pereira J, C Ferreira T, Limbert E, Cavaco BM, Leite V Thyroid. 2022; 32(3) 342-343. doi: 10.1089/thy.2021.0644.
16. Iodine supplementation in pregnancy in an iodine-deficient region: a cross-sectional survey. Carla A Lopes, Susana Prazeres, José Martinez-de-Oliveira, Edward Limbert, Manuel C. Lemos. Nutrients 14, 1393 (2022) doi.org/10.3390/nu14071393
17. Iodine Intake and Related Cognitive Function Impairments in Elementary Schoolchildren. Helga B. Bailote, Diana Linhares, Célia Carvalho, Susana Prazeres, Armindo S. Rodrigues, Patrícia Garcia. Biology 11, 1507 (2022) doi.org/10.3390/biology11101507